Business portfolio centered on the pharmaceuticals business
First written in FY2016. 28 of 30 entries say "Restated". Latest entry: FY2026-H1.
No other company in this theme has enough history to compare yet.
- FY2026-H1RestatedAnnual report
「There were no material changes to the nature of the businesses operated by the company during the current interim accounting period.」
The company states that there has been no material change in its business activities, which include the manufacture and sale of pharmaceuticals and medical equipment, contract manufacturing, and real estate leasing. - FY2024RestatedAnnual report
「The company’s principal businesses include the manufacture and sale of prescription pharmaceuticals and medical equipment, contract manufacturing, and real estate leasing.」
The company continues to operate a business structure that includes the manufacture and sale of pharmaceuticals and medical equipment, contract manufacturing, and real estate leasing. - FY2024-Q3RestatedAnnual report
「There were no material changes in the nature of the businesses conducted by the Company during the first nine months of the current fiscal year.」
The company states that there has been no material change in its business activities, which include the manufacture and sale of pharmaceuticals and medical equipment, contract manufacturing, and real estate leasing. - FY2024-Q2RestatedAnnual report
「There were no material changes to the nature of the businesses operated by the company during the cumulative second quarter.」
The company states that there has been no material change in its business activities, which include the manufacture and sale of pharmaceuticals and medical equipment, contract manufacturing, and real estate leasing. - FY2024-Q1RestatedAnnual report
「There were no material changes to the nature of the businesses operated by the Company during the cumulative first quarter under review.」
The company states that there has been no material change in its business activities, which include the manufacture and sale of pharmaceuticals and medical equipment, contract manufacturing, and real estate leasing. - FY2023Contract manufacturing explicitly identified as a business activityAnnual report
「The company’s principal businesses include the manufacture and sale of prescription pharmaceuticals and medical equipment, contract manufacturing, and real estate leasing.」
In addition to the existing manufacture and sale of pharmaceuticals and medical equipment and real estate leasing, contract manufacturing is explicitly identified as a principal business activity. - FY2023-Q3RestatedAnnual report
「There were no material changes in the nature of the businesses conducted by the Company during the first nine months of the current fiscal year.」
The company states that there has been no material change in its business activities, which include the manufacture and sale of pharmaceuticals and medical equipment and real estate leasing. - FY2023-Q2RestatedAnnual report
「There were no material changes to the nature of the businesses operated by the company during the cumulative second quarter.」
The company states that there has been no material change in its business activities, which include the manufacture and sale of pharmaceuticals and medical equipment and real estate leasing. - FY2023-Q1RestatedAnnual report
「There were no material changes to the nature of the businesses operated by the Company during the cumulative first quarter under review.」
The company states that there has been no material change in its business activities, which include the manufacture and sale of pharmaceuticals and medical equipment and real estate leasing. - FY2022RestatedAnnual report
「The company’s principal businesses are the manufacture and sale of prescription pharmaceuticals and medical equipment, as well as the leasing of real estate.」
The company continues to operate a business structure centered on the manufacture and sale of pharmaceuticals and medical equipment, with real estate leasing also conducted. - FY2022-Q2RestatedAnnual report
「There were no material changes to the nature of the businesses operated by the company during the cumulative second quarter.」
The company states that there has been no material change in its business activities, which include the manufacture and sale of pharmaceuticals and medical equipment and real estate leasing. - FY2021RestatedAnnual report
「The company’s principal businesses are the manufacture and sale of prescription pharmaceuticals and medical equipment, as well as the leasing of real estate.」
The company continues to operate a business structure centered on the manufacture and sale of pharmaceuticals and medical equipment, with real estate leasing also conducted. - FY2021-Q3RestatedAnnual report
「There were no material changes in the nature of the businesses conducted by the Company during the first nine months of the current fiscal year.」
The company states that there has been no material change in its business activities, which include the manufacture and sale of pharmaceuticals and medical equipment and real estate leasing. - FY2021-Q2RestatedAnnual report
「There were no material changes to the nature of the businesses operated by the company during the cumulative second quarter.」
The company states that there has been no material change in its business activities, which include the manufacture and sale of pharmaceuticals and medical equipment and real estate leasing. - FY2021-Q1RestatedAnnual report
「There were no material changes to the nature of the businesses operated by the Company during the cumulative first quarter under review.」
The company states that there has been no material change in its business activities, which include the manufacture and sale of pharmaceuticals and medical equipment and real estate leasing. - FY2020-Q3RestatedAnnual report
「There were no material changes in the nature of the businesses conducted by the Company during the first nine months of the current fiscal year.」
The company states that there has been no material change in its business activities, which include the manufacture and sale of pharmaceuticals and medical equipment and real estate leasing. - FY2020-Q2RestatedAnnual report
「There were no material changes to the nature of the businesses operated by the company during the cumulative second quarter.」
The company states that there has been no material change in its business activities, which include the manufacture and sale of pharmaceuticals and medical equipment and real estate leasing. - FY2020-Q1RestatedAnnual report
「There were no material changes to the nature of the businesses operated by the Company during the cumulative first quarter under review.」
The company states that there has been no material change in its business activities, which include the manufacture and sale of pharmaceuticals and medical equipment and real estate leasing. - FY2019RestatedAnnual report
「The company’s principal businesses are the manufacture and sale of prescription pharmaceuticals and medical equipment, as well as the leasing of real estate.」
The company continues to operate a business structure centered on the manufacture and sale of pharmaceuticals and medical equipment, with real estate leasing also conducted. - FY2019-Q3RestatedAnnual report
「There were no material changes in the nature of the businesses conducted by the Company during the first nine months of the current fiscal year.」
The company states that there has been no material change in its business activities, which include the manufacture and sale of pharmaceuticals and medical equipment and real estate leasing. - FY2019-Q2RestatedAnnual report
「There were no material changes to the nature of the businesses operated by the company during the cumulative second quarter.」
The company states that there has been no material change in its business activities, which include the manufacture and sale of pharmaceuticals and medical equipment and real estate leasing. - FY2019-Q1RestatedAnnual report
「There were no material changes to the nature of the businesses operated by the Company during the cumulative first quarter under review.」
The company states that there has been no material change in its business activities, which include the manufacture and sale of pharmaceuticals and medical equipment and real estate leasing. - FY2018RestatedAnnual report
「The company’s principal businesses are the manufacture and sale of prescription pharmaceuticals and medical equipment, as well as the leasing of real estate.」
The company continues to operate a business structure centered on the manufacture and sale of pharmaceuticals and medical equipment, with real estate leasing also conducted. - FY2018-Q3RestatedAnnual report
「There were no material changes in the nature of the businesses conducted by the Company during the first nine months of the current fiscal year.」
The company states that there has been no material change in its business activities, which include the manufacture and sale of pharmaceuticals and medical equipment and real estate leasing. - FY2018-Q1RestatedAnnual report
「There were no material changes to the nature of the businesses operated by the Company during the cumulative first quarter under review.」
The company states that there has been no material change in its business activities, which include the manufacture and sale of pharmaceuticals and medical equipment and real estate leasing. - FY2017RestatedAnnual report
「The company’s principal businesses are the manufacture and sale of prescription pharmaceuticals and medical equipment, as well as the leasing of real estate.」
There has been no material change in the business structure centered on the manufacture and sale of pharmaceuticals and medical equipment, with real estate leasing also conducted. - FY2017-Q3RestatedAnnual report
「There were no material changes in the nature of the businesses conducted by the Company during the first nine months of the current fiscal year.」
The company states that there has been no material change in its business activities, which include the manufacture and sale of pharmaceuticals and medical equipment and real estate leasing. - FY2017-Q2RestatedAnnual report
「There were no material changes to the nature of the businesses operated by the company during the cumulative second quarter.」
The company states that there has been no material change in its business activities, which include the manufacture and sale of pharmaceuticals and medical equipment and real estate leasing. - FY2017-Q1RestatedAnnual report
「There were no material changes to the nature of the businesses operated by the Company during the cumulative first quarter under review.」
The company states that there has been no material change in its business activities, which include the manufacture and sale of pharmaceuticals and medical equipment and real estate leasing. - FY2016First statedAnnual report
「The company’s principal businesses are the manufacture and sale of prescription pharmaceuticals and medical equipment, as well as the leasing of real estate.」
The company’s core businesses are the manufacture and sale of pharmaceuticals and medical equipment, with real estate leasing also included in its business structure.